Key result
Valve interstitial cells from calcified aortic valves exhibited reduced multipotency, lower expression of stem cell-associated markers, and attenuated myofibroblastic activity compared to cells from healthy valves.
Why the study?
Valve interstitial cells are crucial in the development of calcific aortic valve disease, but differences in phenotype, differentiation potential, and stem cell-like properties between cells from calcified versus healthy aortic valves remained to be compared.
Do valve interstitial cells from calcified aortic valves have reduced differentiation potential and stem cell-like properties compared to cells from healthy valves?
Do valve interstitial cells from calcified aortic valves have reduced differentiation potential and stem cell-like properties compared to cells from healthy valves?
Valve interstitial cells from calcified aortic valves exhibit reduced multipotency and stem cell-like properties compared to healthy valves, suggesting a more committed osteogenic phenotype that may impact the development of medical treatments for aortic valve calcification.
May limit endogenous repair in aortic stenosis; hypothesis-generating for stem cell-targeted therapies.
Valve interstitial cells (VICs) are crucial in the development of calcific aortic valve disease. The purpose of the present investigation was to compare the phenotype, differentiation potential and stem cell-like properties of cells from calcified and healthy aortic valves. VICs were isolated from human healthy and calcified aortic valves. Calcification was induced with osteogenic medium. Unlike VICs from healthy valves, VICs from calcified valves cultured without osteogenic medium stained positively for calcium deposits with Alizarin Red confirming their calcific phenotype. Stimulation of VICs from calcified valves with osteogenic medium increased calcification (p = 0.02), but not significantly different from healthy VICs. When stimulated with myofibroblastic medium, VICs from calcified valves had lower expression of myofibroblastic markers, measured by flow cytometry and RT-qPCR, compared to healthy VICs. Contraction of collagen gel (a measure of myofibroblastic activity) was attenuated in cells from calcified valves (p = 0.04). Moreover, VICs from calcified valves, unlike cells from healthy valves had lower potential to differentiate into adipogenic pathway and lower expression of stem cell-associated markers CD106 (p = 0.04) and aldehyde dehydrogenase (p = 0.04). In conclusion, VICs from calcified aortic have reduced multipotency compared to cells from healthy valves, which should be considered when investigating possible medical treatments of aortic valve calcification.
No takes yet. Share an insight, caveat, or question.
Bogdanova et al. (2019) studied Calcific aortic valve disease. Calcified aortic valves vs. Healthy aortic valves was evaluated on Differentiation potential and stem cell-like properties (e.g., myofibroblastic, osteogenic, adipogenic differentiation, CD106 expression, ALDH activity). Valve interstitial cells from calcified aortic valves exhibited reduced multipotency, lower expression of stem cell-associated markers, and attenuated myofibroblastic activity compared to cells from healthy valves.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: